If you’re being treated for primary hypothyroidism but are still experiencing symptoms, you might consider enrolling in the AVANTI Study of an investigational medication.

Are you 18-75 years of age-
Have you been diagnosed with primary hypothyroidism for at least 12 months-
Have you been on continuous thyroid replacement therapy with an FDA approved dose of Synthroid or Levothyroxine for at least 12 months, and at a stable dose for at least 3 month

New thyroid study now enrolling, for more information call:

Debbie Clark at 901-448-2676 or email her at dmclark@uthsc.edu